Grandfield & Dodd’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.14M | Buy |
18,287
+141
| +0.8% | +$62.8K | 0.48% | 48 |
|
2025
Q1 | $8.8M | Buy |
18,146
+1,182
| +7% | +$573K | 0.55% | 49 |
|
2024
Q4 | $6.83M | Buy |
16,964
+2,820
| +20% | +$1.14M | 0.42% | 53 |
|
2024
Q3 | $6.58M | Buy |
14,144
+2,538
| +22% | +$1.18M | 0.39% | 54 |
|
2024
Q2 | $5.44M | Buy |
11,606
+2,491
| +27% | +$1.17M | 0.34% | 55 |
|
2024
Q1 | $3.81M | Buy |
9,115
+129
| +1% | +$53.9K | 0.24% | 62 |
|
2023
Q4 | $3.66M | Buy |
8,986
+75
| +0.8% | +$30.5K | 0.25% | 60 |
|
2023
Q3 | $3.1M | Sell |
8,911
-107
| -1% | -$37.2K | 0.23% | 65 |
|
2023
Q2 | $3.17M | Buy |
9,018
+30
| +0.3% | +$10.6K | 0.22% | 65 |
|
2023
Q1 | $2.83M | Buy |
8,988
+151
| +2% | +$47.6K | 0.2% | 73 |
|
2022
Q4 | $2.55M | Buy |
8,837
+234
| +3% | +$67.6K | 0.19% | 71 |
|
2022
Q3 | $2.49M | Hold |
8,603
| – | – | 0.2% | 70 |
|
2022
Q2 | $2.42M | Buy |
8,603
+13
| +0.2% | +$3.66K | 0.19% | 74 |
|
2022
Q1 | $2.24M | Buy |
8,590
+150
| +2% | +$39.1K | 0.15% | 75 |
|
2021
Q4 | $1.85M | Buy |
8,440
+519
| +7% | +$114K | 0.12% | 84 |
|
2021
Q3 | $1.44M | Sell |
7,921
-11
| -0.1% | -$2K | 0.1% | 86 |
|
2021
Q2 | $1.6M | Buy |
7,932
+70
| +0.9% | +$14.1K | 0.11% | 83 |
|
2021
Q1 | $1.69M | Buy |
7,862
+19
| +0.2% | +$4.08K | 0.13% | 80 |
|
2020
Q4 | $1.85M | Buy |
7,843
+221
| +3% | +$52.1K | 0.15% | 76 |
|
2020
Q3 | $2.07M | Buy |
7,622
+38
| +0.5% | +$10.3K | 0.19% | 73 |
|
2020
Q2 | $2.2M | Buy |
7,584
+145
| +2% | +$42.1K | 0.21% | 70 |
|
2020
Q1 | $1.77M | Buy |
7,439
+147
| +2% | +$35K | 0.21% | 70 |
|
2019
Q4 | $1.6M | Buy |
7,292
+285
| +4% | +$62.4K | 0.15% | 78 |
|
2019
Q3 | $1.19M | Buy |
7,007
+415
| +6% | +$70.3K | 0.12% | 83 |
|
2019
Q2 | $1.21M | Buy |
6,592
+312
| +5% | +$57.2K | 0.12% | 82 |
|
2019
Q1 | $1.16M | Buy |
6,280
+41
| +0.7% | +$7.54K | 0.12% | 84 |
|
2018
Q4 | $1.03M | Buy |
6,239
+61
| +1% | +$10.1K | 0.12% | 84 |
|
2018
Q3 | $1.19M | Buy |
6,178
+45
| +0.7% | +$8.68K | 0.12% | 85 |
|
2018
Q2 | $1.04M | Buy |
6,133
+15
| +0.2% | +$2.55K | 0.11% | 93 |
|
2018
Q1 | $997K | Sell |
6,118
-130
| -2% | -$21.2K | 0.11% | 93 |
|
2017
Q4 | $936K | Buy |
6,248
+103
| +2% | +$15.4K | 0.1% | 100 |
|
2017
Q3 | $934K | Buy |
6,145
+340
| +6% | +$51.7K | 0.1% | 97 |
|
2017
Q2 | $748K | Buy |
5,805
+90
| +2% | +$11.6K | 0.09% | 107 |
|
2017
Q1 | $625K | Buy |
5,715
+70
| +1% | +$7.66K | 0.08% | 111 |
|
2016
Q4 | $416K | Buy |
5,645
+500
| +10% | +$36.8K | 0.05% | 134 |
|
2016
Q3 | $449K | Buy |
5,145
+305
| +6% | +$26.6K | 0.06% | 127 |
|
2016
Q2 | $416K | Buy |
4,840
+194
| +4% | +$16.7K | 0.06% | 122 |
|
2016
Q1 | $369K | Buy |
4,646
+1,520
| +49% | +$121K | 0.05% | 129 |
|
2015
Q4 | $393K | Buy |
3,126
+505
| +19% | +$63.5K | 0.06% | 123 |
|
2015
Q3 | $273K | Sell |
2,621
-100
| -4% | -$10.4K | 0.05% | 145 |
|
2015
Q2 | $336K | Sell |
2,721
-86
| -3% | -$10.6K | 0.05% | 136 |
|
2015
Q1 | $331K | Hold |
2,807
| – | – | 0.05% | 131 |
|
2014
Q4 | $333K | Hold |
2,807
| – | – | 0.05% | 134 |
|
2014
Q3 | $315K | Buy |
2,807
+60
| +2% | +$6.73K | 0.05% | 131 |
|
2014
Q2 | $260K | Buy |
+2,747
| New | +$260K | 0.04% | 159 |
|